SERPINA1 and alpha 1-antitrypsin deficiency: These include lack of specific clinical information such as certain billing codes, incomplete and missing data in the database, and errors in claims coding, including the possibility that individuals heterozygous for AATD (eg, Pi*MZ) were coded as AATD.